Cargando…
Cisplatin Synergistically Enhances Antitumor Potency of Conditionally Replicating Adenovirus via p53 Dependent or Independent Pathways in Human Lung Carcinoma
Cisplatin is ranked as one of the most powerful and commonly prescribed anti-tumor chemotherapeutic agents which improve survival in many solid tumors including non-small cell lung cancer. However, the treatment of advanced lung cancer is restricted due to chemotherapy resistance. Here, we developed...
Autores principales: | Ali, Sakhawat, Tahir, Muhammad, Khan, Aamir Ali, Chen, Xue Chai, Ling, Ma, Huang, Yinghui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429304/ https://www.ncbi.nlm.nih.gov/pubmed/30841620 http://dx.doi.org/10.3390/ijms20051125 |
Ejemplares similares
-
A tumor targeting oncolytic adenovirus can improve therapeutic outcomes in chemotherapy resistant metastatic human breast carcinoma
por: Sakhawat, Ali, et al.
Publicado: (2019) -
Upregulation of Coxsackie Adenovirus Receptor Sensitizes Cisplatin-Resistant Lung Cancer Cells to CRAd-Induced Inhibition
por: Sakhawat, Ali, et al.
Publicado: (2017) -
Combination of conditionally replicative adenovirus and standard chemotherapies shows synergistic antitumor effect in pancreatic cancer
por: Nelson, Amy R, et al.
Publicado: (2009) -
Mesenchymal stem cell-mediated delivery of therapeutic adenoviral vectors to prostate cancer
por: Muhammad, Tahir, et al.
Publicado: (2019) -
Synergistic antitumor effect of the combination of a dual cancer-specific oncolytic adenovirus and cisplatin on lung cancer cells
por: Jin, Jing, et al.
Publicado: (2018)